| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5576316 | The American Journal of Medicine | 2016 | 14 Pages |
Abstract
More than one-quarter of patients with MSSA bacteremia potentially could be treated with parenteral penicillin, which may offer pharmacokinetic advantages over other beta-lactam drugs and potentially improved outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Matthew P. MDCM, Pierre MD, Alexandre P. DEC, Todd C. MD,